Emergency Department Visits Due to Dyspnea: Association with Inhalation Therapy in COPD and Cases with Adverse Drug Reactions

References

• Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease – 2022 report. Available from: https://goldcopd.org/wp-content/uploads/2021/11/GOLD-REPORT-2022-v1.1-22Nov2021_WMV.pdf. Accessed August 3, 2022.
   Google Scholar
• Murray CJ, Atkinson C, Bhalla K, et al. The state of US health, 1990–2010: burden of diseases, injuries, and risk factors. JAMA. 2013;310:591–608. doi:10.1001/jama.2013.13805
   PubMed Web of Science ®Google Scholar
• Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med. 2017;195(5):557–582.
   PubMed Web of Science ®Google Scholar
• Halpin DM, Miravitlles M, Metzdorf N, Celli B. Impact and prevention of severe exacerbations of COPD: a review of the evidence. Int J Chron Obstruct Pulmon Dis. 2017;12:2891–2908. doi:10.2147/COPD.S139470
   PubMed Web of Science ®Google Scholar
• López-Campos JL, Tan W, Soriano JB. Global burden of COPD. Respirology. 2016;21(1):14–23. doi:10.1111/resp.12660
   PubMed Web of Science ®Google Scholar
• Chrystyn H, Mulley BA, Peake MD. Dose response relation to oral theophylline in severe chronic obstructive airways disease. BMJ. 1988;297:1506–1510. doi:10.1136/bmj.297.6662.1506
   PubMed Web of Science ®Google Scholar
• Gross NJ, Petty TL, Friedman M, et al. Dose response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease. A three-center study. Am Rev Respir Dis. 1989;139:1188–1191. doi:10.1164/ajrccm/139.5.1188
   PubMed Web of Science ®Google Scholar
• Ulrik CS. Efficacy of inhaled salmeterol in the management of smokers with chronic obstructive pulmonary disease: a single centre randomised, double blind, placebo controlled, crossover study. Thorax. 1995;50:750–754. doi:10.1136/thx.50.7.750
   PubMed Web of Science ®Google Scholar
• Tashkin DP, Fabbri LM. Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents. Respir Res. 2010;11:149. doi:10.1186/1465-9921-11-149
   PubMed Web of Science ®Google Scholar
• Singh D, Papi A, Corradi M, et al. Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial. Lancet. 2016;388:9. doi:10.1016/S0140-6736(16)31354-X
   PubMed Web of Science ®Google Scholar
• Vogelmeier C, Buhl R, Burghuber O, et al. unter Mitwirkung der folgenden wissenschaftlichen Fachgesellschaften: deutsche Gesellschaft für Arbeitsmedizin und Umweltmedizin e.V.; Deutsche Gesellschaft für Rehabilitationswissenschaften e.V. Leitlinie zur Diagnostik und Therapie von Patienten mit chronisch obstruktiver Bronchitis und Lungenemphysem (COPD) [Guideline for the Diagnosis and Treatment of COPD Patients - Issued by the German Respiratory Society and the German Atemwegsliga in Cooperation with the Austrian Society of Pneumology]. Pneumologie. 2018. 72(4):253–308. German. PMID: 29523017. doi:10.1055/s-0043-125031
   PubMed Web of Science ®Google Scholar
• Bundesärztekammer (BÄK), Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). Nationale VersorgungsLeitlinie COPD – teilpublikation der Langfassung, 2. Auflage. Version 1; 2021. [National Health Care Guideline COPD - Partial publication of the long version, 2nd edition. Version 1; 2021]. German.
   Google Scholar
• Schurig AM, Bohme M, Just KS, et al. Adverse drug reactions (ADR) and emergencies. Dtsch Arztebl Int. 2018;115(15):251–258.
   PubMed Web of Science ®Google Scholar
• Uppsala Monitoring Centre. The WHO-UMC system. Available from: https://www.who-umc.org/media/2768/standardised-case-causality-assessment.pdf. Accessed June, 12 2017.
   Google Scholar
• Just KS, Dormann H, Böhme M, et al. Personalising drug safety – results from the multi-Centre prospective observational study on adverse drug reactions in emergency departments (ADRED). Eur J Clin Pharmacol. 2019;76(3):439–448. doi:10.1007/s00228-019-02797-9
   PubMed Web of Science ®Google Scholar
• Wood K. The medical dictionary for drug regulatory affairs (MEDDRA) project. Pharmacoepidemiol Drug Saf. 1994;3:7–13. doi:10.1002/pds.2630030105
   Google Scholar
• Bundesärztekammer (BÄK), Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). Nationale VersorgungsLeitlinie COPD – leitlinienreport, 2. Auflage. Version 1; 2021. [National Health Care Guideline COPD - Guideline report, 2nd edition. Version 1; 2021]. German.
   Google Scholar
• Vogelmeier C, Buhl R, Burghuber O, et al. Leitlinie zur Diagnostik und Therapie von Patienten mit chronisch obstruktiver Bronchitis und Lungenemphysem (COPD) [Guideline for the diagnosis and treatment of COPD patients - issued by the German Respiratory Society and the German Atemwegsliga in Cooperation with the Austrian Society of Pneumology]. Pneumologie. 2018;72(4):253–308. doi:10.1055/s-0043-125031
   PubMed Web of Science ®Google Scholar
• Prekker ME, Feemster LC, Hough CL, et al. The epidemiology and outcome of prehospital respiratory distress. Acad Emerg Med. 2014;21:543–550. doi:10.1111/acem.12380
   PubMed Web of Science ®Google Scholar
• Kelly AM, Holdgate A, Keijzers G, et al. Epidemiology, prehospital care and outcomes of patients arriving by ambulance with dyspnoea: an observational study. Scand J Trauma Resusc Emerg Med. 2016;24(1):113. doi:10.1186/s13049-016-0305-5
   PubMed Web of Science ®Google Scholar
• Kelly AM, Holdgate A, Keijzers G, et al. Epidemiology, treatment, disposition and outcome of patients with acute exacerbation of COPD presenting to emergency departments in Australia and South East Asia: an AANZDEM study. Respirology. 2018;23(7):681–686. doi:10.1111/resp.13259
   PubMed Web of Science ®Google Scholar
• Hurst JR, Vestbo J, Anzueto A, et al. Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363(12):1128–1138. PMID: 20843247. doi:10.1056/NEJMoa0909883
   PubMed Web of Science ®Google Scholar
• Guerrero T, Mayordomo C, Sanchez-Agudo L, Nicolau F, Segu JL. Factors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: a multiple logistic regression analysis. Respiration. 2000;67(5):495–501. doi:10.1159/000067462
   PubMed Web of Science ®Google Scholar
• Alcazar B, Garcia-Polo C, Herrejon A, et al. Factors associated with hospital admission for exacerbation of chronic obstructive pulmonary disease. Arch Bronconeumol. 2012;48(3):70–76. doi:10.1016/j.arbr.2012.01.001
   PubMed Web of Science ®Google Scholar
• Niewoehner DE, Lokhnygina Y, Rice K, et al. Risk indexes for exacerbations and hospitalizations due to COPD. Chest. 2007;131(1):20–28. doi:10.1378/chest.06-1316
   PubMed Web of Science ®Google Scholar
• Chavez PC, Shokar NK. Diagnosis and management of chronic obstructive pulmonary disease (COPD) in a primary care clinic. COPD. 2009;6(6):446–451. doi:10.3109/15412550903341455
   PubMedGoogle Scholar
• López-Campos JL, Quintana Gallego E, Carrasco Hernández L. Status of and strategies for improving adherence to COPD treatment. Int J Chron Obstruct Pulmon Dis. 2019;14:1503–1515. doi:10.2147/COPD.S170848
   PubMed Web of Science ®Google Scholar
• Vestbo J, Anderson JA, Calverley PM, et al. Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax. 2009;64(11):939–943. doi:10.1136/thx.2009.113662
   PubMed Web of Science ®Google Scholar
• Wisniewski D, Porzezinska M, Gruchala-Niedoszytko M, Niedoszytko M, Slominski JM, Jassem E. Factors influencing adherence to treatment in COPD patients and its relationship with disease exacerbations. Pneumonol Alergol Pol. 2014;82(2):96–104. doi:10.5603/PiAP.2014.0015
   PubMedGoogle Scholar